In bcr-abl-positive myeloid cells resistant to conventional chemotherapeutic agents, expression of Par-4 increases sensitivity to imatinib (STI571) and histone deacetylase-inhibitors (Q44926027)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | In bcr-abl-positive myeloid cells resistant to conventional chemotherapeutic agents, expression of Par-4 increases sensitivity to imatinib (STI571) and histone deacetylase-inhibitors |
scientific article |
Statements
1 reference
In bcr-abl-positive myeloid cells resistant to conventional chemotherapeutic agents, expression of Par-4 increases sensitivity to imatinib (STI571) and histone deacetylase-inhibitors (English)
1 reference
Angela Brieger
1 reference
Simone Boehrer
1 reference
Simone Schaaf
1 reference
Daniel Nowak
1 reference
Martin Ruthardt
1 reference
Soo-Zin Kim
1 reference
Peter Atadja
1 reference
Dieter Hoelzer
1 reference
Paris S Mitrou
1 reference
Eckhart Weidmann
1 reference
Kai Uwe Chow
1 reference
1 July 2004
1 reference
1 reference
68
1 reference
1
1 reference
85-93
1 reference
Identifiers
1 reference
1 reference